Profile data is unavailable for this security.
About the company
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
- Revenue in JPY (TTM)35.26bn
- Net income in JPY-437.00m
- Incorporated1975
- Employees934.00
- LocationJCR Pharmaceuticals Co Ltd3-19, Kasuga-choASHIYA-SHI 659-0021JapanJPN
- Phone+81 797328591
- Websitehttps://www.jcrpharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seikagaku Corp | 38.36bn | 2.02bn | 46.47bn | 988.00 | 22.15 | 0.593 | 13.86 | 1.21 | 36.93 | 36.93 | 703.10 | 1,379.48 | 0.4679 | 1.93 | 4.88 | 38,827,940.00 | 2.46 | 0.4261 | 2.66 | 0.4678 | 47.98 | 54.18 | 5.25 | 0.9814 | 4.53 | -- | 0.0051 | 465.78 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
| Cuorips Inc | 19.39m | -657.94m | 51.38bn | 59.00 | -- | 8.78 | -- | 2,650.09 | -88.11 | -88.11 | 2.60 | 729.16 | 0.0032 | 1.15 | 10.60 | 328,610.20 | -10.89 | -- | -11.14 | -- | 44.66 | -- | -3,394.40 | -- | 35.37 | -- | 0.00 | -- | -39.65 | -- | -39.84 | -- | -- | -- |
| ASKA Pharmaceutical Holdings Co Ltd | 63.57bn | 5.98bn | 64.82bn | 762.00 | 10.05 | 0.9372 | 7.78 | 1.02 | 210.94 | 210.94 | 2,243.73 | 2,263.17 | 0.7056 | 1.64 | 3.86 | 83,419,940.00 | 6.63 | 4.63 | 8.44 | 5.87 | 49.38 | 46.94 | 9.40 | 6.76 | 1.71 | -- | 0.1064 | 14.86 | 3.94 | 6.12 | 78.03 | 34.04 | -37.89 | 23.36 |
| Katakura Industries Co., Ltd. | 38.12bn | 2.89bn | 72.01bn | 1.04k | 23.26 | 0.8676 | 16.59 | 1.89 | 87.92 | 87.92 | 1,158.05 | 2,357.16 | 0.2725 | 1.99 | 5.37 | 36,650,960.00 | 2.17 | 2.35 | 2.79 | 3.34 | 38.62 | 37.75 | 7.97 | 8.32 | 2.56 | -- | 0.1026 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
| JCR Pharmaceuticals Co Ltd | 35.26bn | -437.00m | 86.63bn | 934.00 | -- | 1.48 | 27.71 | 2.46 | -3.49 | -3.49 | 281.91 | 451.84 | 0.338 | 0.4791 | 2.15 | 37,747,320.00 | -0.3864 | 8.66 | -0.5681 | 13.46 | 71.44 | 74.51 | -1.14 | 18.24 | 0.9827 | -0.8184 | 0.3325 | 30.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
| Kyorin Pharmaceutical Co Ltd | 119.73bn | 4.82bn | 95.43bn | 2.04k | 17.62 | 0.6526 | 10.33 | 0.797 | 83.83 | 83.83 | 2,084.19 | 2,263.35 | 0.6745 | 1.21 | 3.18 | 58,635,650.00 | 2.71 | 3.05 | 3.36 | 3.79 | 42.87 | 47.11 | 4.02 | 4.76 | 1.74 | -- | 0.1593 | 67.74 | 5.53 | 1.02 | 12.68 | -4.98 | 7.41 | -7.06 |
| Nxera Pharma Co Ltd | 29.28bn | -3.71bn | 107.34bn | 350.00 | -- | 1.58 | 425.97 | 3.67 | -41.70 | -41.70 | 332.11 | 753.72 | 0.194 | 2.57 | 6.61 | 83,642,860.00 | -2.46 | -0.6588 | -2.76 | -0.7036 | 75.27 | 89.83 | -12.68 | -4.46 | 3.90 | -6.02 | 0.5060 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Zeria Pharmaceutical Co Ltd | 78.88bn | 9.03bn | 117.98bn | 1.78k | 10.84 | 1.19 | 7.03 | 1.50 | 204.82 | 204.82 | 1,789.40 | 1,858.72 | 0.5418 | 1.50 | 3.71 | 44,387,400.00 | 6.20 | 3.89 | 9.82 | 6.28 | 73.22 | 71.93 | 11.44 | 7.57 | 0.8393 | -- | 0.3508 | 35.09 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
| Torii Pharmaceutical Co Ltd | 58.84bn | 5.28bn | 122.98bn | 583.00 | 22.75 | 0.9996 | 21.59 | 2.09 | 187.71 | 187.71 | 2,093.33 | 4,271.84 | 0.4411 | 2.74 | 2.30 | 100,924,500.00 | 3.96 | 6.52 | 4.39 | 7.35 | 44.46 | 49.55 | 8.97 | 17.98 | 5.19 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Mochida Pharmaceutical Co Ltd | 104.51bn | 4.53bn | 124.78bn | 1.52k | 26.07 | 0.9144 | 16.79 | 1.19 | 127.75 | 127.75 | 2,945.16 | 3,641.81 | 0.6639 | 1.80 | 3.42 | 68,662,940.00 | 2.88 | 4.37 | 3.41 | 5.31 | 49.61 | 52.47 | 4.34 | 6.71 | 3.50 | -- | 0.00 | 45.16 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
Data as of Nov 13 2024. Currency figures normalised to JCR Pharmaceuticals Co Ltd's reporting currency: Japanese Yen JPY
12.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 15 Jul 2024 | 7.09m | 5.47% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 2.22m | 1.71% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 1.96m | 1.51% |
| Nikko Asset Management Co., Ltd.as of 04 Oct 2024 | 992.60k | 0.77% |
| Daiwa Asset Management Co. Ltd.as of 30 Sep 2024 | 969.70k | 0.75% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 912.20k | 0.70% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 769.32k | 0.59% |
| Asset Management One Co., Ltd.as of 03 Oct 2024 | 663.80k | 0.51% |
| Tokio Marine Asset Management Co., Ltd.as of 25 Jan 2024 | 560.70k | 0.43% |
| PineBridge Investments Japan Co., Ltd.as of 30 Jun 2024 | 544.90k | 0.42% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
